Evidence map›Paper›PMID 39469278›Full record

ArticleCureus2024

Scalp Metastasis From Renal Cell Carcinoma: A Rare Case With Rapid Progression.

Mohammed S Alzahrani, Abdulsamad O Alharbi, Abdulaziz Alghamdi, Abdulrahman Mojallid, Mohamed Alghamdi, Abdullrahman Alayyad, Awnallah Alotaibi, Abdulrhman A Alamri, Rehab Fadag, Mohamed Sheta and 4 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mohammed S AlzahraniUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulsamad O AlharbiUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulaziz AlghamdiUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulrahman MojallidUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Mohamed AlghamdiUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdullrahman AlayyadUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Awnallah AlotaibiUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulrhman A AlamriUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Rehab FadagAnatomical Pathologist, Histopathology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Mohamed ShetaOncology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulrahman S KhalilOncology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Ibrahem F AlassiriRadiology, King Fahd Armed Forces Hospital, Jeddah, SAU.
Abdulghani KhogeerSurgery, Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, SAU.
Adel ElatreisyUrology, King Fahd Armed Forces Hospital, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) is a common renal malignancy that frequently metastasizes, though cutaneous metastasis, particularly to the scalp, is rare and generally indicates a poor prognosis. We report a case of scalp metastasis from RCC in a 69-year-old man who presented with unexplained weight loss and painless hematuria. Imaging revealed a 12-cm renal mass with adrenal, pulmonary, and scalp metastases. The patient's condition rapidly deteriorated, and he died one month after the presentation. Hematogenous spread through Batson's plexus might be the primary mechanism of RCC dissemination to the scalp. While targeted therapies have improved the management of metastatic RCC, the prognosis for patients with skin metastases remains poor.

Indexed as

nephrectomyrenal cell carcinomascalp metastasesskin metastasessurgical excision

Identifiers

PMID39469278
PMCPMC11514952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.